نتائج البحث - "Dinesh Kumar Sinha"

المساهمون: Karyopharm, Mateos M.V., Gavriatopoulou M., Facon T., Auner H.W., Leleu X., Hajek R., Dimopoulos M.A., Delimpasi S., Simonova M., Spicka I., Pour L., Kriachok I., Pylypenko H., Doronin V., Usenko G., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A.Z., Anderson L.D., Bahlis N.J., Cavo M., Chai Y., Jeha J., Arazy M., Shah J., Shacham S., Kauffman M.G., Richardson P.G., Grosicki S.

المصدر: Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, SINE compound, Selinexor, Dexamethasone, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Multiple myeloma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Hydrazine, Humans, Diseases of the blood and blood-forming organs, 1112 Oncology and Carcinogenesis, Adverse effect, Molecular Biology, Letter to the Editor, 1102 Cardiorespiratory Medicine and Haematology, RC254-282, Lenalidomide, Antineoplastic Combined Chemotherapy Protocol, Science & Technology, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Exportin-1, Hematology, Triazoles, medicine.disease, Regimen, 030104 developmental biology, Prior Therapy, Hydrazines, 030220 oncology & carcinogenesis, Proteasome inhibitor, Female, RC633-647.5, business, Life Sciences & Biomedicine, medicine.drug, Human

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf7cc61cc2d359ff206c62213e34e08Test
http://hdl.handle.net/10044/1/89189Test

9

Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone

المساهمون: Sanchez L., Leleu X., Beaumont J.L., Yu H., Hudgens S., Simonova M., Auner H.W., Quach H., Delimpasi S., Spicka I., Pour L., Kriachok I., Dimopoulos M.A., Usenko G., Hajek R., Benjamin R., Sinha D.K., Venner C., Illmer T., Garg M.K., Stevens D.A., Jagannath S., Levy M., Anderson L.D., Bahlis N.J., Facon T., Cavo M., Chai Y., Ma X., Tang S., Leong H., Shah J., Shacham S., Kauffman M., Richardson P., Grosicki S., Karyopharm

المصدر: E386
E383

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdcafd469edafb4d03d8289681092dbaTest
http://hdl.handle.net/11585/865053Test

10

Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

المساهمون: Auner H.W., Gavriatopoulou M., Delimpasi S., Simonova M., Spicka I., Pour L., Dimopoulos M.A., Kriachok I., Pylypenko H., Leleu X., Doronin V., Usenko G., Hajek R., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L.D., Bahlis N.J., Facon T., Mateos M.V., Cavo M., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M.G., Richardson P.G., Grosicki S.

مصطلحات موضوعية: Oncology, Male, Gastrointestinal Diseases, Kaplan-Meier Estimate, Severity of Illness Index, Dexamethasone, Bortezomib, 0302 clinical medicine, Retrospective Studie, Antineoplastic Combined Chemotherapy Protocols, Hydrazine, Multicenter Studies as Topic, Age Factor, Multiple myeloma, Randomized Controlled Trials as Topic, Aged, 80 and over, Frailty, Age Factors, Peripheral Nervous System Diseases, Hematology, Middle Aged, Progression-Free Survival, Hydrazines, Tolerability, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Human, Adult, medicine.medical_specialty, Gastrointestinal Disease, Subgroup analysis, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, Severity of illness, medicine, Humans, Progression-free survival, Lenalidomide, Retrospective Studies, Aged, Antineoplastic Combined Chemotherapy Protocol, business.industry, Hematologic Disease, Triazoles, medicine.disease, Hematologic Diseases, Clinical Trials, Phase III as Topic, Peripheral Nervous System Disease, business, 030215 immunology

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98a9cd6d43172e2122cda2b0568bd327Test
https://hdl.handle.net/11585/865006Test

تنقيح النتائج